nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine monophosphate—HINT1—oviduct—ovarian cancer	0.0148	0.0343	CbGeAlD
Adenosine monophosphate—Tenofovir—NME2—ovarian cancer	0.0088	0.594	CrCbGaD
Adenosine monophosphate—PRKAB2—myometrium—ovarian cancer	0.00623	0.0145	CbGeAlD
Adenosine monophosphate—FBP1—myometrium—ovarian cancer	0.00603	0.014	CbGeAlD
Adenosine monophosphate—PYGL—myometrium—ovarian cancer	0.00596	0.0139	CbGeAlD
Adenosine monophosphate—PRKAB2—uterine cervix—ovarian cancer	0.00485	0.0113	CbGeAlD
Adenosine monophosphate—HINT1—myometrium—ovarian cancer	0.00472	0.011	CbGeAlD
Adenosine monophosphate—PYGL—uterine cervix—ovarian cancer	0.00464	0.0108	CbGeAlD
Adenosine monophosphate—PRKAB2—decidua—ovarian cancer	0.00462	0.0107	CbGeAlD
Adenosine monophosphate—HINT1—embryo—ovarian cancer	0.00454	0.0106	CbGeAlD
Adenosine monophosphate—FBP1—decidua—ovarian cancer	0.00447	0.0104	CbGeAlD
Adenosine monophosphate—PYGL—decidua—ovarian cancer	0.00442	0.0103	CbGeAlD
Adenosine monophosphate—PRKAB2—endometrium—ovarian cancer	0.00439	0.0102	CbGeAlD
Adenosine monophosphate—AMPD1—vagina—ovarian cancer	0.00434	0.0101	CbGeAlD
Adenosine monophosphate—FBP1—endometrium—ovarian cancer	0.00424	0.00985	CbGeAlD
Adenosine monophosphate—Cladribine—NR5A1—ovarian cancer	0.00423	0.286	CrCbGaD
Adenosine monophosphate—PYGL—endometrium—ovarian cancer	0.0042	0.00975	CbGeAlD
Adenosine monophosphate—PRKAB1—myometrium—ovarian cancer	0.00405	0.00941	CbGeAlD
Adenosine monophosphate—ACSS1—myometrium—ovarian cancer	0.00393	0.00912	CbGeAlD
Adenosine monophosphate—PYGL—uterus—ovarian cancer	0.00387	0.00898	CbGeAlD
Adenosine monophosphate—PIM1—myometrium—ovarian cancer	0.00382	0.00886	CbGeAlD
Adenosine monophosphate—APRT—myometrium—ovarian cancer	0.00376	0.00874	CbGeAlD
Adenosine monophosphate—ACSS2—myometrium—ovarian cancer	0.00376	0.00874	CbGeAlD
Adenosine monophosphate—ACSL1—myometrium—ovarian cancer	0.00374	0.00869	CbGeAlD
Adenosine monophosphate—HINT1—epithelium—ovarian cancer	0.00371	0.00861	CbGeAlD
Adenosine monophosphate—HINT1—uterine cervix—ovarian cancer	0.00368	0.00854	CbGeAlD
Adenosine monophosphate—CREB1—myometrium—ovarian cancer	0.00354	0.00822	CbGeAlD
Adenosine monophosphate—HINT1—decidua—ovarian cancer	0.0035	0.00814	CbGeAlD
Adenosine monophosphate—CREB1—embryo—ovarian cancer	0.0034	0.00791	CbGeAlD
Adenosine monophosphate—HINT1—endometrium—ovarian cancer	0.00333	0.00772	CbGeAlD
Adenosine monophosphate—FBP1—bone marrow—ovarian cancer	0.00332	0.00771	CbGeAlD
Adenosine monophosphate—PRKAB2—female gonad—ovarian cancer	0.00331	0.00768	CbGeAlD
Adenosine monophosphate—PRKAB2—vagina—ovarian cancer	0.00329	0.00764	CbGeAlD
Adenosine monophosphate—PYGL—bone marrow—ovarian cancer	0.00328	0.00762	CbGeAlD
Adenosine monophosphate—FBP1—female gonad—ovarian cancer	0.0032	0.00743	CbGeAlD
Adenosine monophosphate—FBP1—vagina—ovarian cancer	0.00318	0.00738	CbGeAlD
Adenosine monophosphate—PYGL—female gonad—ovarian cancer	0.00316	0.00735	CbGeAlD
Adenosine monophosphate—PRKAB1—uterine cervix—ovarian cancer	0.00315	0.00732	CbGeAlD
Adenosine monophosphate—PYGL—vagina—ovarian cancer	0.00314	0.0073	CbGeAlD
Adenosine monophosphate—HINT1—gonad—ovarian cancer	0.00308	0.00716	CbGeAlD
Adenosine monophosphate—HINT1—uterus—ovarian cancer	0.00306	0.00712	CbGeAlD
Adenosine monophosphate—ACSS1—uterine cervix—ovarian cancer	0.00306	0.0071	CbGeAlD
Adenosine monophosphate—PRKAB1—decidua—ovarian cancer	0.003	0.00697	CbGeAlD
Adenosine monophosphate—PIM1—uterine cervix—ovarian cancer	0.00297	0.0069	CbGeAlD
Adenosine monophosphate—PRKAB2—testis—ovarian cancer	0.00293	0.00681	CbGeAlD
Adenosine monophosphate—ACSS2—uterine cervix—ovarian cancer	0.00293	0.0068	CbGeAlD
Adenosine monophosphate—APRT—uterine cervix—ovarian cancer	0.00293	0.0068	CbGeAlD
Adenosine monophosphate—ACSS1—decidua—ovarian cancer	0.00291	0.00676	CbGeAlD
Adenosine monophosphate—ACSL1—uterine cervix—ovarian cancer	0.00291	0.00676	CbGeAlD
Adenosine monophosphate—PRKAB1—endometrium—ovarian cancer	0.00285	0.00662	CbGeAlD
Adenosine monophosphate—FBP1—testis—ovarian cancer	0.00284	0.00659	CbGeAlD
Adenosine monophosphate—PIM1—decidua—ovarian cancer	0.00283	0.00657	CbGeAlD
Adenosine monophosphate—PYGL—testis—ovarian cancer	0.00281	0.00652	CbGeAlD
Adenosine monophosphate—AMPD1—lymph node—ovarian cancer	0.00281	0.00652	CbGeAlD
Adenosine monophosphate—ACSS2—decidua—ovarian cancer	0.00279	0.00648	CbGeAlD
Adenosine monophosphate—APRT—decidua—ovarian cancer	0.00279	0.00648	CbGeAlD
Adenosine monophosphate—CREB1—epithelium—ovarian cancer	0.00278	0.00645	CbGeAlD
Adenosine monophosphate—ACSL1—decidua—ovarian cancer	0.00277	0.00644	CbGeAlD
Adenosine monophosphate—ACSS1—endometrium—ovarian cancer	0.00276	0.00642	CbGeAlD
Adenosine monophosphate—HINT1—female reproductive system—ovarian cancer	0.00275	0.0064	CbGeAlD
Adenosine monophosphate—CREB1—uterine cervix—ovarian cancer	0.00275	0.0064	CbGeAlD
Adenosine monophosphate—PRKAA1—uterine cervix—ovarian cancer	0.00275	0.0064	CbGeAlD
Adenosine monophosphate—ADCY1—testis—ovarian cancer	0.00275	0.00639	CbGeAlD
Adenosine monophosphate—PIM1—endometrium—ovarian cancer	0.00269	0.00624	CbGeAlD
Adenosine monophosphate—APRT—endometrium—ovarian cancer	0.00265	0.00615	CbGeAlD
Adenosine monophosphate—ACSS2—endometrium—ovarian cancer	0.00265	0.00615	CbGeAlD
Adenosine monophosphate—PRKAB1—gonad—ovarian cancer	0.00264	0.00614	CbGeAlD
Adenosine monophosphate—ACSL1—endometrium—ovarian cancer	0.00263	0.00611	CbGeAlD
Adenosine monophosphate—PRKAB1—uterus—ovarian cancer	0.00263	0.0061	CbGeAlD
Adenosine monophosphate—CREB1—decidua—ovarian cancer	0.00262	0.0061	CbGeAlD
Adenosine monophosphate—HINT1—bone marrow—ovarian cancer	0.0026	0.00604	CbGeAlD
Adenosine monophosphate—ACSS1—gonad—ovarian cancer	0.00256	0.00595	CbGeAlD
Adenosine monophosphate—HINT1—female gonad—ovarian cancer	0.00251	0.00582	CbGeAlD
Adenosine monophosphate—HINT1—vagina—ovarian cancer	0.00249	0.00579	CbGeAlD
Adenosine monophosphate—CREB1—endometrium—ovarian cancer	0.00249	0.00579	CbGeAlD
Adenosine monophosphate—PIM1—uterus—ovarian cancer	0.00248	0.00575	CbGeAlD
Adenosine monophosphate—ADK—myometrium—ovarian cancer	0.00246	0.00571	CbGeAlD
Adenosine monophosphate—APRT—gonad—ovarian cancer	0.00246	0.00571	CbGeAlD
Adenosine monophosphate—ACSS2—gonad—ovarian cancer	0.00246	0.00571	CbGeAlD
Adenosine monophosphate—APRT—uterus—ovarian cancer	0.00244	0.00567	CbGeAlD
Adenosine monophosphate—ACSS2—uterus—ovarian cancer	0.00244	0.00567	CbGeAlD
Adenosine monophosphate—ACSL1—gonad—ovarian cancer	0.00244	0.00567	CbGeAlD
Adenosine monophosphate—ACSL1—uterus—ovarian cancer	0.00243	0.00563	CbGeAlD
Adenosine monophosphate—SRC—embryo—ovarian cancer	0.0024	0.00557	CbGeAlD
Adenosine monophosphate—PRKAB1—female reproductive system—ovarian cancer	0.00236	0.00548	CbGeAlD
Adenosine monophosphate—PRKAA1—gonad—ovarian cancer	0.00231	0.00537	CbGeAlD
Adenosine monophosphate—CREB1—gonad—ovarian cancer	0.00231	0.00537	CbGeAlD
Adenosine monophosphate—CREB1—uterus—ovarian cancer	0.0023	0.00533	CbGeAlD
Adenosine monophosphate—ACSS1—female reproductive system—ovarian cancer	0.00229	0.00532	CbGeAlD
Adenosine monophosphate—PRKAB1—bone marrow—ovarian cancer	0.00223	0.00518	CbGeAlD
Adenosine monophosphate—PIM1—female reproductive system—ovarian cancer	0.00222	0.00517	CbGeAlD
Adenosine monophosphate—HINT1—testis—ovarian cancer	0.00222	0.00516	CbGeAlD
Adenosine monophosphate—ACSS2—female reproductive system—ovarian cancer	0.0022	0.0051	CbGeAlD
Adenosine monophosphate—APRT—female reproductive system—ovarian cancer	0.0022	0.0051	CbGeAlD
Adenosine monophosphate—ACSL1—female reproductive system—ovarian cancer	0.00218	0.00506	CbGeAlD
Adenosine monophosphate—ACSS1—bone marrow—ovarian cancer	0.00216	0.00502	CbGeAlD
Adenosine monophosphate—PRKAB1—female gonad—ovarian cancer	0.00215	0.00499	CbGeAlD
Adenosine monophosphate—PRKAB1—vagina—ovarian cancer	0.00214	0.00496	CbGeAlD
Adenosine monophosphate—PRKAB2—lymph node—ovarian cancer	0.00213	0.00494	CbGeAlD
Adenosine monophosphate—PIM1—bone marrow—ovarian cancer	0.0021	0.00488	CbGeAlD
Adenosine monophosphate—ACSS1—female gonad—ovarian cancer	0.00208	0.00484	CbGeAlD
Adenosine monophosphate—APRT—bone marrow—ovarian cancer	0.00207	0.00481	CbGeAlD
Adenosine monophosphate—ACSS2—bone marrow—ovarian cancer	0.00207	0.00481	CbGeAlD
Adenosine monophosphate—ACSS1—vagina—ovarian cancer	0.00207	0.00481	CbGeAlD
Adenosine monophosphate—PRKAA1—female reproductive system—ovarian cancer	0.00206	0.00479	CbGeAlD
Adenosine monophosphate—CREB1—female reproductive system—ovarian cancer	0.00206	0.00479	CbGeAlD
Adenosine monophosphate—ACSL1—bone marrow—ovarian cancer	0.00206	0.00478	CbGeAlD
Adenosine monophosphate—FBP1—lymph node—ovarian cancer	0.00206	0.00477	CbGeAlD
Adenosine monophosphate—PYGL—lymph node—ovarian cancer	0.00203	0.00472	CbGeAlD
Adenosine monophosphate—PIM1—female gonad—ovarian cancer	0.00202	0.0047	CbGeAlD
Adenosine monophosphate—PIM1—vagina—ovarian cancer	0.00201	0.00467	CbGeAlD
Adenosine monophosphate—ACSS2—female gonad—ovarian cancer	0.002	0.00464	CbGeAlD
Adenosine monophosphate—APRT—female gonad—ovarian cancer	0.002	0.00464	CbGeAlD
Adenosine monophosphate—ADCY1—lymph node—ovarian cancer	0.00199	0.00463	CbGeAlD
Adenosine monophosphate—APRT—vagina—ovarian cancer	0.00199	0.00461	CbGeAlD
Adenosine monophosphate—ACSS2—vagina—ovarian cancer	0.00199	0.00461	CbGeAlD
Adenosine monophosphate—ACSL1—female gonad—ovarian cancer	0.00198	0.00461	CbGeAlD
Adenosine monophosphate—ACSL1—vagina—ovarian cancer	0.00197	0.00458	CbGeAlD
Adenosine monophosphate—SRC—epithelium—ovarian cancer	0.00196	0.00455	CbGeAlD
Adenosine monophosphate—CREB1—bone marrow—ovarian cancer	0.00195	0.00453	CbGeAlD
Adenosine monophosphate—PRKAA1—bone marrow—ovarian cancer	0.00195	0.00453	CbGeAlD
Adenosine monophosphate—SRC—uterine cervix—ovarian cancer	0.00194	0.00451	CbGeAlD
Adenosine monophosphate—ADK—uterine cervix—ovarian cancer	0.00191	0.00444	CbGeAlD
Adenosine monophosphate—PRKAB1—testis—ovarian cancer	0.00191	0.00443	CbGeAlD
Adenosine monophosphate—PRKAA1—female gonad—ovarian cancer	0.00188	0.00436	CbGeAlD
Adenosine monophosphate—CREB1—female gonad—ovarian cancer	0.00188	0.00436	CbGeAlD
Adenosine monophosphate—CREB1—vagina—ovarian cancer	0.00187	0.00434	CbGeAlD
Adenosine monophosphate—SRC—decidua—ovarian cancer	0.00185	0.00429	CbGeAlD
Adenosine monophosphate—ACSS1—testis—ovarian cancer	0.00185	0.00429	CbGeAlD
Adenosine monophosphate—ADK—decidua—ovarian cancer	0.00182	0.00423	CbGeAlD
Adenosine monophosphate—PIM1—testis—ovarian cancer	0.0018	0.00417	CbGeAlD
Adenosine monophosphate—APRT—testis—ovarian cancer	0.00177	0.00411	CbGeAlD
Adenosine monophosphate—ACSS2—testis—ovarian cancer	0.00177	0.00411	CbGeAlD
Adenosine monophosphate—ACSL1—testis—ovarian cancer	0.00176	0.00409	CbGeAlD
Adenosine monophosphate—PDE4D—female gonad—ovarian cancer	0.00176	0.00408	CbGeAlD
Adenosine monophosphate—ADK—endometrium—ovarian cancer	0.00173	0.00402	CbGeAlD
Adenosine monophosphate—PRKAA1—testis—ovarian cancer	0.00167	0.00387	CbGeAlD
Adenosine monophosphate—CREB1—testis—ovarian cancer	0.00167	0.00387	CbGeAlD
Adenosine monophosphate—SRC—gonad—ovarian cancer	0.00163	0.00378	CbGeAlD
Adenosine monophosphate—HINT1—lymph node—ovarian cancer	0.00161	0.00374	CbGeAlD
Adenosine monophosphate—ADK—gonad—ovarian cancer	0.00161	0.00373	CbGeAlD
Adenosine monophosphate—PDE4D—testis—ovarian cancer	0.00156	0.00362	CbGeAlD
Adenosine monophosphate—Adenosine triphosphate—AKT1—ovarian cancer	0.00152	0.102	CrCbGaD
Adenosine monophosphate—SRC—female reproductive system—ovarian cancer	0.00145	0.00338	CbGeAlD
Adenosine monophosphate—ADK—female reproductive system—ovarian cancer	0.00143	0.00333	CbGeAlD
Adenosine monophosphate—PRKAB1—lymph node—ovarian cancer	0.00138	0.00321	CbGeAlD
Adenosine monophosphate—PDE4B—uterine cervix—ovarian cancer	0.00136	0.00316	CbGeAlD
Adenosine monophosphate—ADK—bone marrow—ovarian cancer	0.00135	0.00314	CbGeAlD
Adenosine monophosphate—ACSS1—lymph node—ovarian cancer	0.00134	0.00311	CbGeAlD
Adenosine monophosphate—SRC—female gonad—ovarian cancer	0.00132	0.00307	CbGeAlD
Adenosine monophosphate—ADK—female gonad—ovarian cancer	0.0013	0.00303	CbGeAlD
Adenosine monophosphate—PIM1—lymph node—ovarian cancer	0.0013	0.00302	CbGeAlD
Adenosine monophosphate—ADK—vagina—ovarian cancer	0.0013	0.00301	CbGeAlD
Adenosine monophosphate—PDE4B—decidua—ovarian cancer	0.0013	0.00301	CbGeAlD
Adenosine monophosphate—ACSS2—lymph node—ovarian cancer	0.00128	0.00298	CbGeAlD
Adenosine monophosphate—APRT—lymph node—ovarian cancer	0.00128	0.00298	CbGeAlD
Adenosine monophosphate—ACSL1—lymph node—ovarian cancer	0.00128	0.00296	CbGeAlD
Adenosine monophosphate—PDE4B—endometrium—ovarian cancer	0.00123	0.00286	CbGeAlD
Adenosine monophosphate—PRKAA1—lymph node—ovarian cancer	0.00121	0.0028	CbGeAlD
Adenosine monophosphate—CREB1—lymph node—ovarian cancer	0.00121	0.0028	CbGeAlD
Adenosine monophosphate—SRC—testis—ovarian cancer	0.00117	0.00273	CbGeAlD
Adenosine monophosphate—ADK—testis—ovarian cancer	0.00116	0.00269	CbGeAlD
Adenosine monophosphate—PDE4B—gonad—ovarian cancer	0.00114	0.00265	CbGeAlD
Adenosine monophosphate—PDE4D—lymph node—ovarian cancer	0.00113	0.00263	CbGeAlD
Adenosine monophosphate—PDE4B—female reproductive system—ovarian cancer	0.00102	0.00237	CbGeAlD
Adenosine monophosphate—PDE4B—bone marrow—ovarian cancer	0.000963	0.00224	CbGeAlD
Adenosine monophosphate—PDE4B—female gonad—ovarian cancer	0.000928	0.00215	CbGeAlD
Adenosine monophosphate—PDE4B—vagina—ovarian cancer	0.000922	0.00214	CbGeAlD
Adenosine monophosphate—SRC—lymph node—ovarian cancer	0.000851	0.00198	CbGeAlD
Adenosine monophosphate—ADK—lymph node—ovarian cancer	0.000839	0.00195	CbGeAlD
Adenosine monophosphate—PDE4B—testis—ovarian cancer	0.000823	0.00191	CbGeAlD
Adenosine monophosphate—PDE4B—lymph node—ovarian cancer	0.000596	0.00139	CbGeAlD
Adenosine monophosphate—Adenosine triphosphate—ABCB1—ovarian cancer	0.000265	0.0179	CrCbGaD
Adenosine monophosphate—CREB1—Adaptive Immune System—AKT1—ovarian cancer	1.66e-05	2.99e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—CTNNB1—ovarian cancer	1.66e-05	2.98e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—PIK3CA—ovarian cancer	1.65e-05	2.98e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MMP9—ovarian cancer	1.65e-05	2.97e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CDKN1B—ovarian cancer	1.65e-05	2.97e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—PTEN—ovarian cancer	1.64e-05	2.95e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—MAPK3—ovarian cancer	1.63e-05	2.95e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—GPCR downstream signaling—AKT1—ovarian cancer	1.63e-05	2.94e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—MAPK1—ovarian cancer	1.62e-05	2.92e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—EGFR—ovarian cancer	1.62e-05	2.92e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—PTEN—ovarian cancer	1.61e-05	2.91e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CASP3—ovarian cancer	1.61e-05	2.91e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IL2—ovarian cancer	1.61e-05	2.9e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL6ST—ovarian cancer	1.61e-05	2.9e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CXCL8—ovarian cancer	1.6e-05	2.89e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—IL6—ovarian cancer	1.6e-05	2.89e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—PIK3CA—ovarian cancer	1.6e-05	2.88e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—AKT1—ovarian cancer	1.6e-05	2.88e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—HRAS—ovarian cancer	1.59e-05	2.87e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—MAPK1—ovarian cancer	1.59e-05	2.86e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—AKT1—ovarian cancer	1.59e-05	2.86e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CCND1—ovarian cancer	1.57e-05	2.83e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—NRAS—ovarian cancer	1.57e-05	2.83e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CAV1—ovarian cancer	1.57e-05	2.83e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CDKN1B—ovarian cancer	1.57e-05	2.82e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—STAT3—ovarian cancer	1.56e-05	2.82e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—NRAS—ovarian cancer	1.56e-05	2.81e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—MAPK1—ovarian cancer	1.55e-05	2.8e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CTNNB1—ovarian cancer	1.55e-05	2.8e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—EGFR—ovarian cancer	1.55e-05	2.8e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—VEGFA—ovarian cancer	1.55e-05	2.79e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—GPCR downstream signaling—AKT1—ovarian cancer	1.55e-05	2.79e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—TP53—ovarian cancer	1.54e-05	2.79e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—STAT3—ovarian cancer	1.53e-05	2.77e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CASP3—ovarian cancer	1.53e-05	2.77e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IL2—ovarian cancer	1.53e-05	2.76e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—NRAS—ovarian cancer	1.53e-05	2.76e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—HRAS—ovarian cancer	1.53e-05	2.76e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—KRAS—ovarian cancer	1.53e-05	2.76e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—PIK3CA—ovarian cancer	1.53e-05	2.75e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MMP9—ovarian cancer	1.52e-05	2.75e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—IL6—ovarian cancer	1.52e-05	2.75e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—PTEN—ovarian cancer	1.52e-05	2.73e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—NRAS—ovarian cancer	1.51e-05	2.71e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—MAPK3—ovarian cancer	1.5e-05	2.71e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PIK3CD—ovarian cancer	1.5e-05	2.7e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—KRAS—ovarian cancer	1.5e-05	2.7e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CCND1—ovarian cancer	1.49e-05	2.69e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PPP2R1A—ovarian cancer	1.49e-05	2.69e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—MAPK3—ovarian cancer	1.49e-05	2.69e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—IL6ST—ovarian cancer	1.49e-05	2.68e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CTNNB1—ovarian cancer	1.48e-05	2.67e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—AKT1—ovarian cancer	1.48e-05	2.67e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—VEGFA—ovarian cancer	1.48e-05	2.67e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—HRAS—ovarian cancer	1.48e-05	2.66e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—KRAS—ovarian cancer	1.47e-05	2.65e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MAPK3—ovarian cancer	1.47e-05	2.64e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—IL6—ovarian cancer	1.46e-05	2.64e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—STAT3—ovarian cancer	1.46e-05	2.64e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—NRAS—ovarian cancer	1.46e-05	2.63e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MMP9—ovarian cancer	1.45e-05	2.61e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—STAT3—ovarian cancer	1.44e-05	2.6e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—PTEN—ovarian cancer	1.44e-05	2.6e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—NRAS—ovarian cancer	1.44e-05	2.6e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—MAPK1—ovarian cancer	1.43e-05	2.58e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—EGFR—ovarian cancer	1.43e-05	2.58e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—APC—ovarian cancer	1.43e-05	2.57e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MYC—ovarian cancer	1.43e-05	2.57e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CDH1—ovarian cancer	1.42e-05	2.57e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—MAPK1—ovarian cancer	1.42e-05	2.56e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—EGFR—ovarian cancer	1.42e-05	2.56e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—IL6—ovarian cancer	1.41e-05	2.55e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—HRAS—ovarian cancer	1.41e-05	2.55e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—AKT1—ovarian cancer	1.41e-05	2.54e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MAPK3—ovarian cancer	1.4e-05	2.52e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MAPK1—ovarian cancer	1.39e-05	2.51e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—EGFR—ovarian cancer	1.39e-05	2.51e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—MAPK3—ovarian cancer	1.38e-05	2.49e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—PIK3CA—ovarian cancer	1.38e-05	2.48e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—EGFR—ovarian cancer	1.37e-05	2.47e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—VEGFA—ovarian cancer	1.37e-05	2.47e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MYC—ovarian cancer	1.36e-05	2.45e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PIK3CD—ovarian cancer	1.36e-05	2.45e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—STAT3—ovarian cancer	1.36e-05	2.44e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—NRAS—ovarian cancer	1.35e-05	2.44e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—IL6—ovarian cancer	1.35e-05	2.44e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—AKT1—ovarian cancer	1.35e-05	2.44e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—KRAS—ovarian cancer	1.35e-05	2.43e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—PIK3CA—ovarian cancer	1.35e-05	2.43e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—KRAS—ovarian cancer	1.34e-05	2.42e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—MYC—ovarian cancer	1.34e-05	2.42e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—TP53—ovarian cancer	1.33e-05	2.4e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MAPK1—ovarian cancer	1.33e-05	2.4e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—EGFR—ovarian cancer	1.33e-05	2.4e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—ERBB2—ovarian cancer	1.32e-05	2.39e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—KRAS—ovarian cancer	1.32e-05	2.38e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—MAPK1—ovarian cancer	1.31e-05	2.37e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—EGFR—ovarian cancer	1.31e-05	2.36e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PIK3CB—ovarian cancer	1.31e-05	2.36e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MTOR—ovarian cancer	1.31e-05	2.36e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—AKT1—ovarian cancer	1.3e-05	2.35e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—VEGFA—ovarian cancer	1.3e-05	2.35e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—HRAS—ovarian cancer	1.3e-05	2.34e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—KRAS—ovarian cancer	1.3e-05	2.34e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MAPK3—ovarian cancer	1.29e-05	2.33e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—STAT3—ovarian cancer	1.29e-05	2.32e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—NRAS—ovarian cancer	1.29e-05	2.32e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—PIK3CA—ovarian cancer	1.28e-05	2.31e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—HRAS—ovarian cancer	1.27e-05	2.3e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MYC—ovarian cancer	1.26e-05	2.27e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—KRAS—ovarian cancer	1.26e-05	2.27e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CXCL8—ovarian cancer	1.26e-05	2.27e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PIK3CD—ovarian cancer	1.25e-05	2.26e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—HRAS—ovarian cancer	1.25e-05	2.25e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—AKT1—ovarian cancer	1.25e-05	2.25e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—IL6—ovarian cancer	1.24e-05	2.24e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—PIK3CA—ovarian cancer	1.24e-05	2.24e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—KRAS—ovarian cancer	1.24e-05	2.23e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—PIK3CA—ovarian cancer	1.23e-05	2.22e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MAPK1—ovarian cancer	1.23e-05	2.22e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—EGFR—ovarian cancer	1.23e-05	2.22e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MAPK3—ovarian cancer	1.23e-05	2.22e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CDKN1B—ovarian cancer	1.23e-05	2.21e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—PIK3CA—ovarian cancer	1.21e-05	2.18e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CASP3—ovarian cancer	1.2e-05	2.17e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IL2—ovarian cancer	1.2e-05	2.17e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—ERBB2—ovarian cancer	1.2e-05	2.16e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MYC—ovarian cancer	1.2e-05	2.16e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—IL6—ovarian cancer	1.19e-05	2.15e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—PIK3CA—ovarian cancer	1.19e-05	2.15e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TERT—ovarian cancer	1.19e-05	2.14e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MTOR—ovarian cancer	1.18e-05	2.14e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PIK3CB—ovarian cancer	1.18e-05	2.14e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MAPK1—ovarian cancer	1.17e-05	2.11e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—EGFR—ovarian cancer	1.17e-05	2.11e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—TP53—ovarian cancer	1.17e-05	2.11e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CCND1—ovarian cancer	1.17e-05	2.11e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—KRAS—ovarian cancer	1.16e-05	2.1e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CTNNB1—ovarian cancer	1.16e-05	2.09e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—PIK3CA—ovarian cancer	1.15e-05	2.08e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—HRAS—ovarian cancer	1.15e-05	2.07e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—AKT1—ovarian cancer	1.15e-05	2.07e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—HRAS—ovarian cancer	1.14e-05	2.06e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—PIK3CA—ovarian cancer	1.14e-05	2.05e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MMP9—ovarian cancer	1.14e-05	2.05e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PTEN—ovarian cancer	1.13e-05	2.04e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—AKT1—ovarian cancer	1.13e-05	2.03e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—HRAS—ovarian cancer	1.12e-05	2.02e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—TP53—ovarian cancer	1.12e-05	2.01e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CDKN1B—ovarian cancer	1.11e-05	2e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—ERBB2—ovarian cancer	1.11e-05	2e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—KRAS—ovarian cancer	1.11e-05	2e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—AKT1—ovarian cancer	1.1e-05	1.99e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—HRAS—ovarian cancer	1.1e-05	1.99e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—IL6—ovarian cancer	1.1e-05	1.98e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CAV1—ovarian cancer	1.1e-05	1.98e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PIK3CB—ovarian cancer	1.09e-05	1.97e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MTOR—ovarian cancer	1.09e-05	1.97e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IL6—ovarian cancer	1.09e-05	1.97e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL2—ovarian cancer	1.09e-05	1.96e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IL6—ovarian cancer	1.07e-05	1.93e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—PIK3CA—ovarian cancer	1.07e-05	1.93e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—HRAS—ovarian cancer	1.07e-05	1.93e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—ESR1—ovarian cancer	1.06e-05	1.91e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—HRAS—ovarian cancer	1.05e-05	1.9e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CTNNB1—ovarian cancer	1.05e-05	1.89e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—AKT1—ovarian cancer	1.04e-05	1.88e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL6ST—ovarian cancer	1.04e-05	1.88e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—TP53—ovarian cancer	1.03e-05	1.86e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CDKN1B—ovarian cancer	1.03e-05	1.85e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PTEN—ovarian cancer	1.02e-05	1.85e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IL6—ovarian cancer	1.02e-05	1.84e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—VEGFA—ovarian cancer	1.02e-05	1.84e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—PIK3CA—ovarian cancer	1.02e-05	1.83e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—AKT1—ovarian cancer	1.01e-05	1.83e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—STAT3—ovarian cancer	1.01e-05	1.82e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—NRAS—ovarian cancer	1.01e-05	1.82e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—IL6—ovarian cancer	1.01e-05	1.82e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—AKT1—ovarian cancer	1.01e-05	1.82e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PIK3CG—ovarian cancer	1e-05	1.8e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—APC—ovarian cancer	1e-05	1.8e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—HRAS—ovarian cancer	9.89e-06	1.78e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—AKT1—ovarian cancer	9.89e-06	1.78e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—TP53—ovarian cancer	9.84e-06	1.77e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—AKT1—ovarian cancer	9.73e-06	1.75e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CTNNB1—ovarian cancer	9.7e-06	1.75e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MAPK3—ovarian cancer	9.65e-06	1.74e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IL6—ovarian cancer	9.47e-06	1.71e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PTEN—ovarian cancer	9.45e-06	1.7e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—AKT1—ovarian cancer	9.43e-06	1.7e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—HRAS—ovarian cancer	9.41e-06	1.7e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MYC—ovarian cancer	9.39e-06	1.69e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—AKT1—ovarian cancer	9.3e-06	1.68e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MAPK1—ovarian cancer	9.19e-06	1.66e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—EGFR—ovarian cancer	9.18e-06	1.66e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—STAT3—ovarian cancer	9.16e-06	1.65e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—NRAS—ovarian cancer	9.13e-06	1.65e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IL6—ovarian cancer	9e-06	1.62e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PIK3CD—ovarian cancer	8.79e-06	1.58e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MAPK3—ovarian cancer	8.75e-06	1.58e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—AKT1—ovarian cancer	8.73e-06	1.57e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—KRAS—ovarian cancer	8.68e-06	1.56e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—STAT3—ovarian cancer	8.45e-06	1.52e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—NRAS—ovarian cancer	8.43e-06	1.52e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MAPK1—ovarian cancer	8.32e-06	1.5e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—EGFR—ovarian cancer	8.32e-06	1.5e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—AKT1—ovarian cancer	8.31e-06	1.5e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MAPK3—ovarian cancer	8.08e-06	1.46e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PIK3CA—ovarian cancer	7.97e-06	1.44e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—KRAS—ovarian cancer	7.86e-06	1.42e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MYC—ovarian cancer	7.85e-06	1.42e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—ERBB2—ovarian cancer	7.76e-06	1.4e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—TP53—ovarian cancer	7.71e-06	1.39e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MAPK1—ovarian cancer	7.68e-06	1.39e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—EGFR—ovarian cancer	7.68e-06	1.39e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PIK3CB—ovarian cancer	7.66e-06	1.38e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MTOR—ovarian cancer	7.66e-06	1.38e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—HRAS—ovarian cancer	7.37e-06	1.33e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CXCL8—ovarian cancer	7.36e-06	1.33e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—KRAS—ovarian cancer	7.26e-06	1.31e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PIK3CA—ovarian cancer	7.22e-06	1.3e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CDKN1B—ovarian cancer	7.19e-06	1.3e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IL6—ovarian cancer	7.06e-06	1.27e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CASP3—ovarian cancer	7.04e-06	1.27e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL2—ovarian cancer	7.03e-06	1.27e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCND1—ovarian cancer	6.86e-06	1.24e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CTNNB1—ovarian cancer	6.79e-06	1.22e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—HRAS—ovarian cancer	6.68e-06	1.2e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PIK3CA—ovarian cancer	6.67e-06	1.2e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MMP9—ovarian cancer	6.66e-06	1.2e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PTEN—ovarian cancer	6.62e-06	1.19e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—AKT1—ovarian cancer	6.51e-06	1.17e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL6—ovarian cancer	6.39e-06	1.15e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—HRAS—ovarian cancer	6.17e-06	1.11e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—VEGFA—ovarian cancer	5.98e-06	1.08e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—STAT3—ovarian cancer	5.92e-06	1.07e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—NRAS—ovarian cancer	5.9e-06	1.06e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—IL6—ovarian cancer	5.9e-06	1.06e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—AKT1—ovarian cancer	5.9e-06	1.06e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MAPK3—ovarian cancer	5.66e-06	1.02e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MYC—ovarian cancer	5.5e-06	9.92e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—AKT1—ovarian cancer	5.45e-06	9.82e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MAPK1—ovarian cancer	5.38e-06	9.7e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—EGFR—ovarian cancer	5.38e-06	9.7e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—KRAS—ovarian cancer	5.08e-06	9.16e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PIK3CA—ovarian cancer	4.67e-06	8.42e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TP53—ovarian cancer	4.52e-06	8.14e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—HRAS—ovarian cancer	4.32e-06	7.79e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL6—ovarian cancer	4.13e-06	7.45e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—AKT1—ovarian cancer	3.81e-06	6.88e-06	CbGpPWpGaD
